000 | 01935 a2200517 4500 | ||
---|---|---|---|
005 | 20250514211546.0 | ||
264 | 0 | _c20050119 | |
008 | 200501s 0 0 eng d | ||
022 | _a0007-1048 | ||
024 | 7 |
_a10.1111/j.1365-2141.2004.05240.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSpaner, David E | |
245 | 0 | 0 |
_aEffect of IL-2R beta-binding cytokines on costimulatory properties of chronic lymphocytic leukaemia cells: implications for immunotherapy. _h[electronic resource] |
260 |
_bBritish journal of haematology _cDec 2004 |
||
300 |
_a531-42 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aADP-ribosyl Cyclase _ximmunology |
650 | 0 | 4 | _aADP-ribosyl Cyclase 1 |
650 | 0 | 4 |
_aAntigen-Presenting Cells _ximmunology |
650 | 0 | 4 |
_aAntigens, CD _ximmunology |
650 | 0 | 4 |
_aB-Lymphocytes _ximmunology |
650 | 0 | 4 |
_aB7-1 Antigen _ximmunology |
650 | 0 | 4 | _aB7-2 Antigen |
650 | 0 | 4 | _aCell Proliferation |
650 | 0 | 4 | _aCytotoxicity Tests, Immunologic |
650 | 0 | 4 | _aDose-Response Relationship, Immunologic |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFlow Cytometry |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunotherapy, Active _xmethods |
650 | 0 | 4 |
_aInterleukin-15 _xtherapeutic use |
650 | 0 | 4 |
_aInterleukin-2 _xtherapeutic use |
650 | 0 | 4 | _aInterleukin-2 Receptor beta Subunit |
650 | 0 | 4 |
_aInterleukins _xtherapeutic use |
650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _ximmunology |
650 | 0 | 4 | _aLymphocyte Activation |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMembrane Glycoproteins _ximmunology |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aReceptors, Interleukin _xmetabolism |
700 | 1 | _aHammond, Caitlin | |
700 | 1 | _aMena, Jenny | |
700 | 1 | _aShi, Yonghong | |
773 | 0 |
_tBritish journal of haematology _gvol. 127 _gno. 5 _gp. 531-42 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2141.2004.05240.x _zAvailable from publisher's website |
999 |
_c15251968 _d15251968 |